Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Photosensitivity disorders
MeSH D010787 - photosensitivity disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012871:
Skin diseases
34 Companies
17 Drugs
$
Success rate
D010787:
Photosensitivity disorders
33 Companies
23 Drugs
$
Success rate
D006837:
Hydroa vacciniforme
0 Companies
0 Drugs
Success rate
D013471:
Sunburn
14 Companies
2 Drugs
$
Success rate
D014983:
Xeroderma pigmentosum
0 Companies
0 Drugs
Success rate
D017454:
Photoallergic dermatitis
0 Companies
0 Drugs
Success rate
D017484:
Phototoxic dermatitis
0 Companies
0 Drugs
Success rate
D000092130:
Solar urticaria
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
3/3
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Hydroxychloroquine
,
Vitamin a
Sandoz
Hydroxychloroquine
Bayer
Vitamin a
L'Oréal
Avobenzone
,
Octocrylene
,
Titanium dioxide
Allergan
Ascorbic acid
,
Cyanocobalamin
,
Ergocalciferol
,
Folic acid
,
Riboflavin
,
Vitamin a
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use